Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000109

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 17, 2017
Accepted (ET)
Aug 23, 2017 · 1:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 17, 2017P3,000$0.0284A22,450,889D
Common StockAug 17, 2017P3,000$0.0284A22,453,889D
Common StockAug 17, 2017P3,000$0.0276A22,456,889D
Common StockAug 17, 2017P3,000$0.0271A22,459,889D
Common StockAug 17, 2017P3,000$0.0284A22,462,889D
Common StockAug 17, 2017P5,000$0.0273A22,467,889D
Common StockAug 17, 2017P2,000$0.0268A22,469,889D
Common StockAug 17, 2017P3,000$0.0268A22,472,889D
Common StockAug 17, 2017P5,000$0.0268A22,477,889D
Common StockAug 17, 2017P2,000$0.0268A22,479,889D
Common StockAug 17, 2017P3,000$0.0268A22,482,889D
Common StockAug 17, 2017P5,000$0.0268A22,487,889D
Common StockAug 17, 2017P5,000$0.0268A22,492,889D
Common StockAug 17, 2017P2,000$0.0267A22,494,889D
Common StockAug 18, 2017P3,000$0.0263A22,497,889D
Common StockAug 18, 2017P3,000$0.0263A22,500,889D
Common StockAug 18, 2017P3,000$0.0263A22,503,889D
Common StockAug 18, 2017P3,000$0.0262A22,506,889D
Common StockAug 18, 2017P3,000$0.0245A22,509,889D
Common StockAug 18, 2017P3,000$0.0258A22,512,889D
Common StockAug 18, 2017P5,000$0.0259A22,517,889D
Common StockAug 18, 2017P5,000$0.0259A22,522,889D
Common StockAug 18, 2017P3,000$0.0259A22,525,889D
Common StockAug 18, 2017P3,000$0.0256A22,528,889D
Common StockAug 18, 2017P2,000$0.0259A22,530,889D

Table II — derivative securities

No Table II lines on this filing.